cabergoline has been researched along with Overweight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aberer, F; Obermayer-Pietsch, B; Pandis, M; Pieber, TR; Pilz, S; Posawetz, AS; Theiler-Schwetz, V; Trummer, C | 1 |
| Okazaki, K; Sugimoto, T; Takeno, A; Yamaguchi, T; Yamamoto, M | 1 |
2 other study(ies) available for cabergoline and Overweight
| Article | Year |
|---|---|
Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study.
Topics: Adiposity; Adult; Austria; Body Composition; Body Mass Index; Cabergoline; Case-Control Studies; Dyslipidemias; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Lipid Metabolism; Male; Middle Aged; Overweight; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult | 2021 |
Successful Improvement of Metabolic Disorders, Including Osteopenia, by a Dopamine Agonist in a Male Patient with Macro-Prolactinoma.
Topics: Adult; Bone Diseases, Metabolic; Cabergoline; Dopamine Agonists; Ergolines; Glucose Intolerance; Humans; Hypertriglyceridemia; Male; Overweight; Pituitary Neoplasms; Prolactinoma | 2016 |